Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jordan Karlitz to Colorectal Neoplasms

This is a "connection" page, showing publications Jordan Karlitz has written about Colorectal Neoplasms.

 
Connection Strength
  
 
 
8.316
  
  1. Greene M, Stieber B, Ozbay AB, Anderson J, LeMaster J, Dore M, Stukalin I, Arroyo J, Ebner DW, Fendrick AM, Karlitz JJ. Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity. J Natl Compr Canc Netw. 2026 Jul; 24(7).
    View in: PubMed
    Score: 0.546
  2. Greene M, Stieber B, LeMaster JW, Idriss R, Stukalin I, Zapatier J, Arroyo J, Anderson J, Karlitz JJ. Closing the loop in colorectal cancer screening: real-world adherence to follow-up colonoscopy after positive mt-sDNA vs FIT/FOBT, stratified by payer type. Curr Med Res Opin. 2025 Sep; 41(9):1629-1639.
    View in: PubMed
    Score: 0.521
  3. Greene M, Gohil S, Stieber B, Ozbay AB, Le QA, Kakuturu R, LeMaster JW, Dore M, Fendrick AM, Anderson JC, Karlitz JJ. Utilization of colorectal cancer screening modalities in the United States (2017-2023): a national multi-payer claims database analysis. Curr Med Res Opin. 2025 Sep; 41(9):1619-1628.
    View in: PubMed
    Score: 0.519
  4. Montminy EM, Zhou M, Edelson JC, Karlitz JJ. Stage-Stratified Incidence Rates of Colorectal Adenocarcinoma Among Patients Aged 46 to 49 in the United States. JAMA Netw Open. 2024 03 04; 7(3):e241848.
    View in: PubMed
    Score: 0.465
  5. Montminy EM, Zhou M, Maniscalco L, Heda R, Kim MK, Patel SG, Wu XC, Itzkowitz SH, Karlitz JJ. Shifts in the Proportion of Distant Stage Early-Onset Colorectal Adenocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2022 02; 31(2):334-341.
    View in: PubMed
    Score: 0.402
  6. Karlitz JJ, Fendrick AM, Bhatt J, Coronado GD, Jeyakumar S, Smith NJ, Plescia M, Brooks D, Limburg P, Lieberman D. Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population. Popul Health Manag. 2022 06; 25(3):343-351.
    View in: PubMed
    Score: 0.399
  7. Montminy EM, Zhou M, Maniscalco L, Penrose H, Yen T, Patel SG, Wu XC, Karlitz JJ. Trends in the Incidence of Early-Onset Colorectal Adenocarcinoma Among Black and White US Residents Aged 40 to 49 Years, 2000-2017. JAMA Netw Open. 2021 11 01; 4(11):e2130433.
    View in: PubMed
    Score: 0.395
  8. Karlitz JJ, Montminy EM, Itzkowitz SH. Adenocarcinomas, as Opposed to Carcinoids, Are Primarily Driving Increases in Early-Onset Colorectal Cancer Rates. Gastroenterology. 2021 11; 161(5):1723-1724.
    View in: PubMed
    Score: 0.379
  9. Montminy EM, Zhou M, Maniscalco L, Abualkhair W, Kim MK, Siegel RL, Wu XC, Itzkowitz SH, Karlitz JJ. Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States. Ann Intern Med. 2021 02; 174(2):157-166.
    View in: PubMed
    Score: 0.372
  10. Montminy EM, Jang A, Conner M, Karlitz JJ. Screening for Colorectal Cancer. Med Clin North Am. 2020 Nov; 104(6):1023-1036.
    View in: PubMed
    Score: 0.369
  11. Abualkhair WH, Zhou M, Ochoa CO, Lacayo L, Murphy C, Wu XC, Karlitz JJ. Geographic and intra-racial disparities in early-onset colorectal cancer in the SEER 18 registries of the United States. Cancer Med. 2020 12; 9(23):9150-9159.
    View in: PubMed
    Score: 0.368
  12. Molmenti CL, Kolb JM, Karlitz JJ. Advanced Colorectal Polyps on Colonoscopy: A Trigger for Earlier Screening of Family Members. Am J Gastroenterol. 2020 03; 115(3):311-314.
    View in: PubMed
    Score: 0.352
  13. Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu XC, Karlitz JJ. Trends in Incidence of Early-Onset Colorectal Cancer in the United States Among Those Approaching Screening Age. JAMA Netw Open. 2020 01 03; 3(1):e1920407.
    View in: PubMed
    Score: 0.348
  14. Karlitz JJ, Oliphant AB, Greenwald DA, Pochapin MB. The American College of Gastroenterology and the 80% by 2018 Colorectal Cancer Initiative: A Multifaceted Approach to Maximize Screening Rates. Am J Gastroenterol. 2017 Sep; 112(9):1360-1362.
    View in: PubMed
    Score: 0.295
  15. Noll A, Parekh PJ, Karlitz JJ. Diagnosis of Lynch syndrome before colorectal resection: does it matter? Tech Coloproctol. 2016 Apr; 20(4):203-5.
    View in: PubMed
    Score: 0.266
  16. Karlitz J, Provenzale D. Invited comment on Warrier et al: hereditary colorectal cancer screening and management practices by colorectal surgeons. Tech Coloproctol. 2014 Mar; 18(3):313-4.
    View in: PubMed
    Score: 0.226
  17. Karlitz JJ. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med. 2009 Jun 02; 150(11):816; author reply 819-20.
    View in: PubMed
    Score: 0.167
  18. Gohil S, Omar M, Carnes ML, Karlitz JJ, Usry N, Idriss R, Greene M. Adherence to multi-target stool DNA colorectal cancer screening among Medicare patients in Alabama. Curr Med Res Opin. 2026 May; 42(5):941-951.
    View in: PubMed
    Score: 0.137
  19. Gohil S, Omar M, Karlitz J, Young P, Greene M. Multi-target stool DNA test adherence among individuals screened for colorectal cancer through the US Defense Health Agency. Curr Med Res Opin. 2026 Feb; 42(2):195-203.
    View in: PubMed
    Score: 0.135
  20. Greene M, Camardo M, Karlitz JJ, Nowd P, Wang W, Anderson J, Kisiel J, Ebner D. Real-world adherence to multi-target stool DNA testing and its association with time to follow-up colonoscopy: a health-system analysis from Massachusetts General Hospital. Curr Med Res Opin. 2026 Feb; 42(2):205-219.
    View in: PubMed
    Score: 0.134
  21. Greene M, Camardo M, Karlitz JJ, Nowd P, Son J, Fuerstein J, Li J, Rittner S. Adherence to multi-target stool DNA test and time to follow-up colonoscopy: real-world analysis of patients from the Beth Israel Lahey Health. Curr Med Res Opin. 2025 Oct; 41(10):1811-1823.
    View in: PubMed
    Score: 0.131
  22. Greene M, Anderson J, LeMaster J, Arroyo J, Zapatier J, Bingham J, Kakuturu R, Karlitz JJ, Le Q. Real-World Adherence to Repeat Colorectal Cancer Screening With the Multi-Target Stool DNA Test in a Large, Insured, and Average-Risk Population. Cancer Med. 2025 Nov; 14(21):e71314.
    View in: PubMed
    Score: 0.130
  23. Greene M, Le QA, Ozbay AB, Karlitz JJ, Fendrick AM. Completing the colorectal cancer screening process: impact of eliminating cost-sharing for follow-up colonoscopy. Curr Med Res Opin. 2025 Sep; 41(9):1697-1703.
    View in: PubMed
    Score: 0.130
  24. Gohil S, D'Attilio D, Paladiya R, Ganguly A, Vergara CM, Karlitz JJ, Greene M. Adherence to multi-target stool DNA colorectal cancer screening and clinical follow-up in the Hartford HealthCare system. Int J Colorectal Dis. 2025 Sep 16; 40(1):200.
    View in: PubMed
    Score: 0.129
  25. Greene M, Pew T, Sakthisivabalan L, Zapatier J, Arroyo J, López JVR, Karlitz JJ, Duarte M. Adherence to colorectal cancer screening with multi-target stool DNA testing among first-time average-risk users in federally qualified health centers. Curr Med Res Opin. 2025 Jun; 41(6):983-993.
    View in: PubMed
    Score: 0.128
  26. Greene M, Pew T, Ozbay AB, Rincón López JV, Brooks D, Karlitz J, Duarte M. Impact of Spanish Language Outreach on Multi-Target Stool DNA Test Adherence in a Federally Qualified Health Center in the United States. Cancer Control. 2025 Jan-Dec; 32:10732748251343334.
    View in: PubMed
    Score: 0.126
  27. Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. Comparison of trends in early-onset colorectal cancer in North America and Europe - Authors' reply. Lancet Gastroenterol Hepatol. 2022 06; 7(6):506.
    View in: PubMed
    Score: 0.103
  28. Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022 03; 7(3):262-274.
    View in: PubMed
    Score: 0.100
  29. Yen T, Scolaro J, Montminy E, Karlitz JJ, Wani S, Patel SG. Spectrum of Advanced Colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50. Clin Gastroenterol Hepatol. 2023 03; 21(3):827-829.e3.
    View in: PubMed
    Score: 0.099
  30. Fendrick AM, Fisher DA, Saoud L, Ozbay AB, Karlitz JJ, Limburg PJ. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes. Cancer Prev Res (Phila). 2021 09; 14(9):845-850.
    View in: PubMed
    Score: 0.096
  31. Fisher DA, Karlitz JJ, Jeyakumar S, Smith N, Limburg P, Lieberman D, Fendrick AM. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population. J Med Econ. 2021 Jan-Dec; 24(1):654-664.
    View in: PubMed
    Score: 0.093
  32. Dwyer AJ, Murphy CC, Boland CR, Garcia R, Hampel H, Limburg P, Lowery J, Zauber AG, Waring S, Worrall S, Perea J, Siegel R, Lee J, Molmenti C, Sears CL, Buckhaults P, Hayes R, Hussan H, de Miranda N, Palles C, Diaz L, Song M, Cercek A, Lieu CH, Patel SG, Karlitz JJ, Cao Y, Demb J, Blatchford P, Risendal B, Staples ES, Wali A, Daschner P, Loomans-Kropp H, Flores R, Levell CL, Wehling K, Martin J, Pesmen C, Kuchar V, Soisson R, Davis A, Ahnen D. A Summary of the Fight Colorectal Cancer Working Meeting: Exploring Risk Factors and Etiology of Sporadic Early-Age Onset Colorectal Cancer. Gastroenterology. 2019 08; 157(2):280-288.
    View in: PubMed
    Score: 0.083
  33. Montminy EM, Karlitz JJ, Landreneau SW. Progress of colorectal cancer screening in United States: Past achievements and future challenges. Prev Med. 2019 03; 120:78-84.
    View in: PubMed
    Score: 0.081
  34. Charlton ME, Karlitz JJ, Schlichting JA, Chen VW, Lynch CF. Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study. Am J Clin Oncol. 2017 Oct; 40(5):498-506.
    View in: PubMed
    Score: 0.074
  35. Chen VW, Hsieh MC, Charlton ME, Ruiz BA, Karlitz J, Altekruse SF, Ries LA, Jessup JM. Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system. Cancer. 2014 Dec 01; 120 Suppl 23:3793-806.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)